Armando de Feria, MD
Internal Medicine · Pembroke Pines, FLNPI 1639179807
Payments from drug & device makers
Across 260 payments — averaging $45,400 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bavarian Nordic A/s$6.3M
- Pfizer$2.7M
- Modernatx, Inc.$2.3M
- Biohaven Pharmaceutical Holding Company Ltd.$246K
- Biohaven Pharmaceuticals, Inc.$222K
- Eli Lilly$30K
- plus $22K from 23 others
Across 9 payments — averaging $20,113 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$180K
- Eli Lilly$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bavarian Nordic A/s | 74 | $6,337,808 |
| Pfizer | 60 | $2,676,088 |
| Modernatx, Inc. | 52 | $2,269,815 |
| Biohaven Pharmaceutical Holding Company Ltd. | 17 | $246,048 |
| Biohaven Pharmaceuticals, Inc. | 4 | $221,903 |
| Eli Lilly | 2 | $30,000 |
| Sanofi US Services Inc. | 8 | $15,724 |
| Bristol Myers Squibb | 2 | $3,277 |
| Sanofi-aventis U.S. LLC | 1 | $2,400 |
| Chiesi USA, Inc. | 2 | $200 |
| Novartis | 5 | $99 |
| Johnson & Johnson(2 entities) | 4 | $75 |
| Sunovion Pharmaceuticals Inc. | 4 | $58 |
| Zyla Life Sciences, Inc. | 3 | $51 |
| Kowa Pharmaceuticals America, Inc. | 2 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $49 |
| Amarin Pharma, Inc. | 3 | $47 |
| Bayer | 2 | $43 |
| AbbVie(2 entities) | 2 | $33 |
| Hologic Sales And Service, LLC | 1 | $33 |
| Novo Nordisk | 2 | $31 |
| Exact Sciences | 1 | $28 |
| GSK | 1 | $22 |
| AstraZeneca | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| Merck | 1 | $16 |
| Renalytix AI, Inc. | 1 | $16 |
| Tolmar, Inc. | 1 | $14 |
| Amgen | 1 | $11 |
How this compares
$11,803,982 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Pembroke Pines
- Jaynier MoyaPembroke Pines$45.4M
- Yanely Pineiro PueblaPembroke Pines$12.4M
- Maria BermudezPembroke Pines$10.2M
- Robert PerryPembroke Pines$9.2M
- Ernesto FuentesPembroke Pines$9M
- Giralt Yanez RamosPembroke Pines$5.5M
- Kenneth BlazePembroke Pines$4.3M
- Reynold Duarte MartinezPembroke Pines$4.1M
- Yaneicy Gonzalez RojasCoral Gables$93.5M
- Juan Carlos RondonHollywood$66.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.